Turning Point Benefit Group’s Labcorp LH Stock Holding History

Turning Point Benefit Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8	Closed	-$2.01K	–	482
2025 Q4	$2.01K	Buy	+8	New	+$2.13K	﹤0.01%	446

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Turning Point Benefit Group's LH Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Labcorp (LH) in Q1 2026, closing a stake of 8 shares — an estimated $2.01K sold.

Turning Point Benefit Group first reported a position in LH in Q4 2025 and held it in 1 quarter. The position peaked at $2.01K in Q4 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Turning Point Benefit Group reported no remaining Labcorp position as of Q1 2026 after selling out during the quarter.
Turning Point Benefit Group sold 8 Labcorp shares in Q1 2026, an estimated $2.01K.
Turning Point Benefit Group first reported a position in Labcorp in Q4 2025 and held it in 1 quarter.
Turning Point Benefit Group's Labcorp position peaked at $2.01K in Q4 2025.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.